One-year access to more than 500 world journals available in the system
http://medilib.ir
- Duration of Time : 365 Day
Price
: 300$
- Special Price
: 100$
Order
Journals package 3months
http://medilib.ir
- Duration of Time : 93 Day
- :
Price
: 100$
- Special Price
: 50$
Order
Lebrikizumab is associated with improvements in patient-reported symptoms and quality-of-life measures across Eczema Area and Severity Index response categories: pooled results from phase-3 randomized ADvocate1 and ADvocate2 studies in patients with moderate-to-severe atopic dermatitis
doi : 10.1080/09546634.2024.2442720
Buy The Package and View The Article Online